SD-208 | m-entrepreneurship.com

Product Name :
SD-208

Search keywords :
SD-208

drugId :
null

Target Vo:
Transforming growth factor beta receptor 1

Target Vo Short Name :
TGFBR1

Moa_Name:
Transforming growth factor beta receptor 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Scios

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Glioma

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RAGE Antibody medchemexpress
E-Cadherin Mouse mAb supplier
PAX6 Antibody: PAX6 Antibody is an antibody targeting to PAX6.

Author: Betaine hydrochloride

Related Posts